{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:03:52Z","timestamp":1779905032716,"version":"3.53.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,27]]},"DOI":"10.7759\/cureus.109754","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:24:46Z","timestamp":1779902686000},"source":"Crossref","is-referenced-by-count":0,"title":["Angiocentric Variant of Primary Cutaneous CD30-Positive Anaplastic Large Cell Lymphoma: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Mariana","family":"Herrera Ocampo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Roa Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Shuchleib Cukiert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Hern\u00e1ndez Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S","family":"Parra Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Vega Memije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2022.104126","article-title":"Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification","volume":"51","author":"Willemze R","year":"2022","unstructured":"Willemze R. Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification. Presse Med. 2022, 51:104126. 10.1016\/j.lpm.2022.104126","journal-title":"Presse Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002852","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714","volume":"134","author":"Willemze R","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, et al.. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714. Blood. 2019, 134:1112. 10.1182\/blood.2019002852","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13117","article-title":"Primary cutaneous CD30(+) lymphoproliferative disorders","volume":"14","author":"Wieser I","year":"2016","unstructured":"Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M. Primary cutaneous CD30(+) lymphoproliferative disorders. J Dtsch Dermatol Ges. 2016, 14:767-82. 10.1111\/ddg.13117","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.17023","article-title":"Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects","volume":"57","author":"Tsuyama N","year":"2017","unstructured":"Tsuyama N, Sakamoto K, Sakata S, Dobashi A, Takeuchi K. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. J Clin Exp Hematop. 2017, 57:120-42. 10.3960\/jslrt.17023","journal-title":"J Clin Exp Hematop"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2011.80","article-title":"Perils and pitfalls regarding differential diagnosis and treatment of primary cutaneous anaplastic large-cell lymphoma","volume":"11","author":"Diamantidis MD","year":"2011","unstructured":"Diamantidis MD, Myrou AD. Perils and pitfalls regarding differential diagnosis and treatment of primary cutaneous anaplastic large-cell lymphoma. ScientificWorldJournal. 2011, 11:1048-55. 10.1100\/tsw.2011.80","journal-title":"ScientificWorldJournal"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164098","article-title":"Primary cutaneous anaplastic large cell lymphoma-a review of clinical, morphological, immunohistochemical, and molecular features","volume":"15","author":"Ortiz-Hidalgo C","year":"2023","unstructured":"Ortiz-Hidalgo C, Pina-Oviedo S. Primary cutaneous anaplastic large cell lymphoma-a review of clinical, morphological, immunohistochemical, and molecular features. Cancers (Basel). 2023, 15:10.3390\/cancers15164098","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12937","article-title":"Primary cutaneous anaplastic large cell lymphoma","volume":"44","author":"Brown RA","year":"2017","unstructured":"Brown RA, Fernandez-Pol S, Kim J. Primary cutaneous anaplastic large cell lymphoma. J Cutan Pathol. 2017, 44:570-7. 10.1111\/cup.12937","journal-title":"J Cutan Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/jomfp.JOMFP_177_19","article-title":"The \"hallmark\" cells","volume":"23","author":"Pandiar D","year":"2019","unstructured":"Pandiar D, Smitha T. The \"hallmark\" cells. J Oral Maxillofac Pathol. 2019, 23:176-7. 10.4103\/jomfp.JOMFP_177_19","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2020.09.024","article-title":"The utility and limitations of B- and T-cell gene rearrangement studies in evaluating lymphoproliferative disorders","volume":"53","author":"Mendoza H","year":"2021","unstructured":"Mendoza H, Tormey CA, Rinder HM, Howe JG, Siddon AJ. The utility and limitations of B- and T-cell gene rearrangement studies in evaluating lymphoproliferative disorders. Pathology. 2021, 53:157-65. 10.1016\/j.pathol.2020.09.024","journal-title":"Pathology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqab012","article-title":"How I diagnose anaplastic large cell lymphoma","volume":"155","author":"Amador C","year":"2021","unstructured":"Amador C, Feldman AL. How I diagnose anaplastic large cell lymphoma. Am J Clin Pathol. 2021, 155:479-97. 10.1093\/ajcp\/aqab012","journal-title":"Am J Clin Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf W","year":"2011","unstructured":"Kempf W, Pfaltz K, Vermeer MH, et al.. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood. 2011, 118:4024-35. 10.1182\/blood-2011-05-351346","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2016.1122514","article-title":"Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management","volume":"9","author":"Bennani-Baiti N","year":"2016","unstructured":"Bennani-Baiti N, Ansell S, Feldman AL. Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management. Expert Rev Hematol. 2016, 9:137-50. 10.1586\/17474086.2016.1122514","journal-title":"Expert Rev Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071650","article-title":"Anaplastic large cell lymphoma: molecular pathogenesis and treatment","volume":"14","author":"Zhang XR","year":"2022","unstructured":"Zhang XR, Chien PN, Nam SY, Heo CY. Anaplastic large cell lymphoma: molecular pathogenesis and treatment. Cancers (Basel). 2022, 14:10.3390\/cancers14071650","journal-title":"Cancers (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184667","article-title":"ALK-negative anaplastic large cell lymphoma: current concepts and molecular pathogenesis of a heterogeneous group of large T-cell lymphomas","volume":"13","author":"Pina-Oviedo S","year":"2021","unstructured":"Pina-Oviedo S, Ortiz-Hidalgo C, Carballo-Zarate AA, Zarate-Osorno A. ALK-negative anaplastic large cell lymphoma: current concepts and molecular pathogenesis of a heterogeneous group of large T-cell lymphomas. Cancers (Basel). 2021, 13:10.3390\/cancers13184667","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2021.12.001","article-title":"Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: a retrospective analysis of treatment outcomes and selection for high or low dose schedule","volume":"33","author":"Smits K","year":"2022","unstructured":"Smits K, Quint KD, Vermeer MH, et al.. Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: a retrospective analysis of treatment outcomes and selection for high or low dose schedule. Clin Transl Radiat Oncol. 2022, 33:77-82. 10.1016\/j.ctro.2021.12.001","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2022.2049233","article-title":"Emerging drugs for the treatment of cutaneous T-cell lymphoma","volume":"27","author":"Cheng M","year":"2022","unstructured":"Cheng M, Zain J, Rosen ST, Querfeld C. Emerging drugs for the treatment of cutaneous T-cell lymphoma. Expert Opin Emerg Drugs. 2022, 27:45-54. 10.1080\/14728214.2022.2049233","journal-title":"Expert Opin Emerg Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492482-angiocentric-variant-of-primary-cutaneous-cd30-positive-anaplastic-large-cell-lymphoma-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:24:47Z","timestamp":1779902687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492482-angiocentric-variant-of-primary-cutaneous-cd30-positive-anaplastic-large-cell-lymphoma-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.109754","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}